The Biologic Therapeutic Drug Market has emerged as one of the most transformative segments within the global healthcare industry, driven by advancements in biotechnology and increasing demand for ...

Rectal adenocarcinoma, eosinophilic esophagitis, inflammatory bowel disease, diverticular perforation, and irritable bowel syndrome are among the gastrointestinal adverse events associated with the ...

A review of 10 articles finds that nearly 9% of adverse event (AE) reports with biologics used to treat psoriasis were gastrointestinal (GI)-related and suggests that the relative rate may be higher ...

Biologics are complex medications produced through biological processes or from living organisms such as proteins and genes. Biosimilars are what they sound like — similar to, but not the same as, an ...

Biologics (also called biological medications) are a complex class of drugs derived from living organisms, such as plant or animal cells. They’re made by reproducing copies of living cells that have ...

Benjamin Lockshin, MD, FAAD, examines the non-clinical reasons driving real-world treatment discontinuation and explains how clinicians use primary versus secondary loss of efficacy to guide biologic ...

Among patients with inflammatory bowel disease (IBD), overlapping biologic therapy was common during medication switches and was not associated with a higher risk for infection than nonoverlapping ...